Clinical Trial Update: Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI [Phase 1, Phase 2]

View source ↗

Summary

This document reports long-term follow-up results from a Phase 1/2 trial evaluating autologous bone marrow mononuclear cell therapy in patients with myocardial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• Autologous bone marrow mononuclear cells (bone marrow mononuclear cells)

Snippet

Sponsor: Xijing Hospital | Conditions: Myocardial Infarction | Phase 1, Phase 2 | Status: UNKNOWN